8-K: NeOnc Technologies Secures $1.45M in Equity and Warrants

NeOnc Technologies Holdings, Inc. announced the closing of an initial tranche of a new securities purchase agreement, raising $1.45 million for working capital.

Summary

• NeOnc Technologies Holdings, Inc. (the Company) entered into a new Securities Purchase Agreement on February 24, 2026.
• The agreement involves the issuance and sale of up to 746,973 shares of common stock at $7.20 per share and five-year warrants to purchase up to 746,973 shares of common stock at an exercise price of $9.00 per share.
• An initial closing under this new agreement occurred on February 25, 2026, resulting in the issuance of 201,390 shares and warrants to purchase 201,390 shares to four investors.
• This initial closing generated a combined purchase price of $1,450,004.
• The offering under this new Securities Purchase Agreement terminated on February 28, 2026.
• The Company intends to use the net proceeds from this offering for working capital purposes.
• The securities were issued under an exemption from registration requirements (Section 4(a)(2) of the Securities Act).
• The Company will file a resale registration statement for these shares and warrant shares no later than 10 days after filing its Annual Report on Form 10-K for the year ended December 31, 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, as it successfully secures additional working capital, which is essential for operations. However, the dilution from new share issuance and future warrant exercise presents a neutral to slightly negative aspect for existing shareholders.

Positives

• Successfully raised $1,450,004 in capital from four investors, providing funds for working capital.
• The capital raise is a continuation of a previously disclosed financing strategy.

Negatives

• The issuance of new shares and warrants could lead to dilution for existing shareholders.
• The exercise price of the warrants ($9.00) is higher than the share purchase price ($7.20), indicating a potential future dilution at a higher valuation.

Risks

• The securities have not been registered with the SEC and are subject to resale restrictions unless an effective registration statement is in place or an exemption (like Rule 144) is available.
• Exercise of warrants is subject to a Beneficial Ownership Limitation of 9.99% to prevent any single holder from exceeding this threshold.
• Future equity sales at a lower effective price per share than the current warrant exercise price could trigger anti-dilution adjustments, reducing the warrant exercise price.
• The Company is obligated to indemnify investors against certain losses, claims, damages, liabilities, or expenses related to the resale registration statement, which could incur legal and other costs.

Future Outlook

The Company plans to use the net proceeds from this offering for working capital purposes. A resale registration statement for the newly issued shares and warrant shares will be filed no later than 10 days after the Company's Annual Report on Form 10-K for the year ended December 31, 2025, is filed.

Management Comments

• The Company intends to use the net proceeds from the offering for working capital purposes.

Industry Context

StockSavvy.ai notes that this capital raise is a common strategy for growth-oriented companies to secure funding for ongoing operations and strategic initiatives. The structure of issuing both shares and warrants is typical for private placements, balancing immediate capital infusion with potential future upside for investors.

Comparison to Industry Standards

• The filing does not provide sufficient information to make specific comparisons to comparable companies, projects, or results within the industry. It primarily details a financing transaction.

Stakeholder Impact

• Shareholders: Potential dilution from the issuance of new shares and future exercise of warrants. The capital raise provides funds for company operations, which could support long-term value.
• Investors (new): Acquired common stock and warrants with a five-year term, offering potential upside if the stock price increases above the exercise price.

Next Steps

• The Company will file a resale registration statement for the Shares and Warrant Shares no later than 10 days after the filing of its Annual Report on Form 10-K for the year ended December 31, 2025.
• The Company will use the net proceeds for working capital purposes.

Key Dates

Keywords

Equity Offering, Warrants, Capital Raise, SEC Filing, Common Stock, Securities Purchase Agreement, Working Capital, Dilution, Registration Statement, NEONC TECHNOLOGIES HOLDINGS, INC.